These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25089121)

  • 1. Making use of equity sensitive QALYs: a case study on identifying the worse off across diseases.
    Lindemark F; Norheim OF; Johansson KA
    Cost Eff Resour Alloc; 2014; 12():16. PubMed ID: 25089121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconciliation of economic concerns and health policy: illustration of an equity adjustment procedure using proportional shortfall.
    Stolk EA; van Donselaar G; Brouwer WB; Busschbach JJ
    Pharmacoeconomics; 2004; 22(17):1097-107. PubMed ID: 15612829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifetime QALY prioritarianism in priority setting: quantification of the inherent trade-off.
    Ottersen T; Mæstad O; Norheim OF
    Cost Eff Resour Alloc; 2014 Jan; 12(1):2. PubMed ID: 24418267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.
    Clarke A; Pulikottil-Jacob R; Grove A; Freeman K; Mistry H; Tsertsvadze A; Connock M; Court R; Kandala NB; Costa M; Suri G; Metcalfe D; Crowther M; Morrow S; Johnson S; Sutcliffe P
    Health Technol Assess; 2015 Jan; 19(10):1-668, vii-viii. PubMed ID: 25634033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cost-Effectiveness of Bimodal Stimulation Compared to Unilateral and Bilateral Cochlear Implant Use in Adults with Bilateral Severe to Profound Deafness.
    Theriou C; Fielden CA; Kitterick PT
    Ear Hear; 2019; 40(6):1425-1436. PubMed ID: 30998548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss.
    Hernæs UJV; Johansson KA; Ottersen T; Norheim OF
    Pharmacoeconomics; 2017 Sep; 35(9):965-974. PubMed ID: 28625004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model.
    Bond M; Mealing S; Anderson R; Elston J; Weiner G; Taylor RS; Hoyle M; Liu Z; Price A; Stein K
    Health Technol Assess; 2009 Sep; 13(44):1-330. PubMed ID: 19799825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime QALY prioritarianism in priority setting.
    Ottersen T
    J Med Ethics; 2013 Mar; 39(3):175-80. PubMed ID: 23204320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria of candidacy for unilateral cochlear implantation in postlingually deafened adults II: cost-effectiveness analysis.
    UK Cochlear Implant Study Group
    Ear Hear; 2004 Aug; 25(4):336-60. PubMed ID: 15292775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(1):1-165. PubMed ID: 32194878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure.
    Gao L; Moodie M
    BMJ Open; 2019 Sep; 9(9):e031033. PubMed ID: 31492790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Technology Assistance be Cost Effective in TKA? A Simulation-Based Analysis of a Risk-prioritized, Practice-specific Framework.
    Hickey MD; Masri BA; Hodgson AJ
    Clin Orthop Relat Res; 2023 Jan; 481(1):157-173. PubMed ID: 36073992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concerns for severity in priority setting in health care: a review of trade-off data in preference studies and implications for societal willingness to pay for a QALY.
    Nord E; Johansen R
    Health Policy; 2014 Jun; 116(2-3):281-8. PubMed ID: 24690334
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.